Defining borderline resectable pancreatic cancer: emerging consensus for an old challenge.

作者信息

Malafa Mokenge P

出版信息

J Natl Compr Canc Netw. 2015 May;13(5):501-4. doi: 10.6004/jnccn.2015.0068.

DOI:10.6004/jnccn.2015.0068

PMID:25964634

Abstract

摘要

相似文献

Defining borderline resectable pancreatic cancer: emerging consensus for an old challenge.

J Natl Compr Canc Netw. 2015 May;13(5):501-4. doi: 10.6004/jnccn.2015.0068.

Staging of pancreatic cancer: resectable, borderline resectable, and unresectable disease.

Abdom Radiol (NY). 2018 Feb;43(2):301-313. doi: 10.1007/s00261-017-1410-2.

Defining venous involvement in borderline resectable pancreatic cancer.

Ann Surg Oncol. 2010 Nov;17(11):2832-8. doi: 10.1245/s10434-010-1284-9. Epub 2010 Aug 20.

Surgical treatment of resectable and borderline resectable pancreatic cancer: expert consensus statement by Evans et al.

Ann Surg Oncol. 2009 Jul;16(7):1745-50. doi: 10.1245/s10434-009-0410-z. Epub 2009 Apr 24.

Surgical treatment of resectable and borderline resectable pancreas cancer: expert consensus statement.

Ann Surg Oncol. 2009 Jul;16(7):1736-44. doi: 10.1245/s10434-009-0416-6. Epub 2009 Apr 23.

New developments in the management of borderline resectable pancreatic cancer.

JOP. 2013 Mar 10;14(2):123-5. doi: 10.6092/1590-8577/1473.

Preoperative ultrasound ablation for borderline resectable pancreatic cancer: A report of 30 cases.

Ultrason Sonochem. 2015 Nov;27:694-702. doi: 10.1016/j.ultsonch.2015.05.029. Epub 2015 Jun 9.

Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement by Callery et al.

Ann Surg Oncol. 2009 Jul;16(7):1734-5. doi: 10.1245/s10434-009-0411-y. Epub 2009 Apr 24.

Contemporary Management of Borderline Resectable and Locally Advanced Unresectable Pancreatic Cancer.

Oncologist. 2016 Feb;21(2):178-87. doi: 10.1634/theoncologist.2015-0316. Epub 2016 Feb 1.

Applicability of current NCCN Guidelines for pancreatic adenocarcinoma resectability: analysis and pitfalls.

Abdom Radiol (NY). 2018 Feb;43(2):314-322. doi: 10.1007/s00261-018-1459-6.

引用本文的文献

KIFC1 Overexpression Promotes Pancreatic Carcinoma Progression via Stabilising BUB1B.

J Cell Mol Med. 2025 Aug;29(16):e70767. doi: 10.1111/jcmm.70767.

Role of minimally invasive surgery in the management of localized pancreatic ductal adenocarcinoma: a review.

J Robot Surg. 2024 Feb 22;18(1):85. doi: 10.1007/s11701-024-01825-w.

Imaging of pancreatic ductal adenocarcinoma - An update for all stages of patient management.

Eur J Radiol Open. 2024 Feb 8;12:100553. doi: 10.1016/j.ejro.2024.100553. eCollection 2024 Jun.

Surgical Feasibility, Determinants, and Overall Efficacy of Neoadjuvant Lu-DOTATATE PRRT for Locally Advanced Unresectable Gastroenteropancreatic Neuroendocrine Tumors.

J Nucl Med. 2021 Nov;62(11):1558-1563. doi: 10.2967/jnumed.120.258772. Epub 2021 Feb 26.

Next Generation Immunotherapy for Pancreatic Cancer: DNA Vaccination is Seeking New Combo Partners.

Cancers (Basel). 2018 Feb 16;10(2):51. doi: 10.3390/cancers10020051.

Multimodality Management of "Borderline Resectable" Pancreatic Neuroendocrine Tumors: Report of a Single-Institution Experience.

Cancer Control. 2017 Oct-Dec;24(5):1073274817729076. doi: 10.1177/1073274817729076.

Neoadjuvant Therapy of Pancreatic Cancer: Definitions and Benefits.

Int J Mol Sci. 2017 Jul 26;18(8):1622. doi: 10.3390/ijms18081622.

Updated therapeutic outcome for patients with periampullary and pancreatic cancer related to recent translational research.

World J Gastroenterol. 2016 Dec 28;22(48):10502-10511. doi: 10.3748/wjg.v22.i48.10502.

Anti-α-enolase antibody limits the invasion of myeloid-derived suppressor cells and attenuates their restraining effector T cell response.

Oncoimmunology. 2015 Dec 21;5(5):e1112940. doi: 10.1080/2162402X.2015.1112940. eCollection 2016 May.

CA19-9 Normalization During Pre-operative Treatment Predicts Longer Survival for Patients with Locally Progressed Pancreatic Cancer.

J Gastrointest Surg. 2016 Jul;20(7):1331-42. doi: 10.1007/s11605-016-3149-4. Epub 2016 Apr 25.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Suppr
超能文献

Defining borderline resectable pancreatic cancer: emerging consensus for an old challenge.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

Suppr超能文献

Defining borderline resectable pancreatic cancer: emerging consensus for an old challenge.

作者信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

Suppr
超能文献